Skip to content

Assessment of the Performance of a New Ostomy Device in Subjects Having an Ileostomy

Assessment of the Performance of a New Ostomy Device in Sub-jects Having an Ileostomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03439241
Enrollment
20
Registered
2018-02-20
Start date
2018-02-05
Completion date
2018-04-16
Last updated
2018-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ileostomy - Stoma

Brief summary

The purpose was to investigate the performance of a new ostomy device measured with a measuring device.

Interventions

the test product is a newly developed Coloplast ostomy device

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

The trial starts with a baseline period. After 4 baseplate changes the subjects is randomised into two arms.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Have given written informed consent and in DK: signed a letter of authority 2. Be at least 18 years of age and have full legal capacity 3. Have had their ileostomy for at least 3 months 4. Can use a product with max cut size 45 mm 5. Self-reported problems with leakage (3 x within 14 days) 6. Be willing and suitable (determined by the investigator representative) to use the test product without using a paste/mouldable ring during the test period 7. Must be able to use custom cut product 8. Minimum change of product every third day 9. Get a negative result of a pregnancy test for women of childbearing age (only DK)

Exclusion criteria

1. Are currently receiving or have within the past 2 months received radio-and/or chemotherapy (low doses chemotherapy is allowed for other indications than cancer, e.g. below 15 mg methotrexate for rheumatoid arthritis) 2. Are currently receiving or have within the past month received topical steroid treatment in the peristomal skin area, e.g. lotion or spray. Systemic steroid treatment (e.g. injection, or tablet) are allowed. 3. Are pregnant or breastfeeding 4. Are participating in other interventional clinical investigations or have previously participated in this investigation Exception: Participation in other Coloplast in-house clinical investigations is accepted under the circumstances that the subject has paused the activities in the investigation and are otherwise complying with the inclusion and

Design outcomes

Primary

MeasureTime frameDescription
wear time (hours)14 daysWear time is recorded at each baseplate change

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026